Although studies have yet to investigate the contribution of IL-17 to oral complications in SSc patients, elevated IL-17 messenger RNA (RNA) and protein expression in the lesional skin and peripheral blood mononuclear cells of SSc patients have been reported (Shima 2021). This evidence concerns the gene IL17A and systemic sclerosis.